All practice-based pharmacist articles
-
NICE guidelineNICE guideline on the treatment of human and animal bites
Overview This summary provides an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance. It includes a visual summary of the ...
-
SIGN guideline
SIGN guideline on bacterial UTIs in women
This guidance provides advice on the managment of suspected bacterial lower urinary tract infection in adult women
-
Independent professional body guideline
In practice: guidance for pharmacist prescribers
This guidance sets out the key areas pharmacist prescribers should consider when applying GPhC standards to their prescribing practice
-
PHE/DH/DWP guideline
PHE management of patient/staff exposure to COVID-19
This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.
-
PHE/DH/DWP guideline
PHE UTI guideline
A brief guide to the diagnosis and management of UTIs in primary care, which includes clear algorithms for the assessment of urinary symptoms.
-
Independent professional body guideline
BASHH vulvovaginal candidiasis guideline
Recommendations on the diagnostic tests, treatment regimens, and health promotion principles for the effective management of vulvovaginal candidiasis
-
Independent professional body guideline
AWMSG asthma guideline
Core principles of asthma management, inhaler selection and use, and referral guidance, from the All Wales Medicines Strategy Group
-
NICE guideline
NICE antimicrobial prescribing guideline for insect bites and stings
This Guidelines summary covers an antimicrobial prescribing strategy for insect and spider bites and stings in adults, young people, and children
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19.
-
SIGN guideline
SIGN osteoporosis guideline
A brief summary of SIGN's guideline on management of osteoporosis and prevention of fragility fractures, including risk factors and a treatment algorithm.
-
Information
Key COVID-19 guidance for community pharmacy
The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of professional bodies.
-
NICE guideline
NICE vitamin D guideline
An up-to-date summary of the recommendations set out in the NICE guideline on increasing vitamin D supplement use among groups at risk of deficiency.
